The tumor suppressor gene p53 can mediate transforming the growth factor β1-induced differentiation of leukemic cells independently of activation of the retinoblastoma protein

Cell Growth and Differentiation

Volumn 8, Issue 10, 1997, Pages 1127-1137

  Ehinger, Mats ^a,b   Bergh, Gösta ^a   Johnsson, Ellinor ^a   Gullberg, Urban ^a   Olsson, Inge ^a  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CELL DIFFERENTIATION; ERYTHROLEUKEMIA CELL; GROWTH INHIBITION; GROWTH REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN SYNTHESIS REGULATION; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE;

APOPTOSIS; CELL DIFFERENTIATION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DOSE-RESPONSE RELATIONSHIP, DRUG; GENES, P53; HUMANS; LEUKEMIA; LEUKOCYTES; MUTATION; PHOSPHORYLATION; RETINOBLASTOMA PROTEIN; TEMPERATURE; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 0030764166     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Hollstein, M., Sidransky, D., Vogelstein, B., and Harris, C. C. p53-mutations in human cancers. Science (Washington DC), 253: 49-53, 1991.
2. Ahuja, H., Bar Eli, E., Arlin, Z., Advani, S., Allen, S. L., Goldman, J., Snyder, D., Foti, A., and Cline, M. The spectrum of molecular alterations in the evolution of chronic myelocytic leukemia. J. Clin. Invest., 87: 2042-2047, 1991.
3. Fenaux, P., Jonveaux, P., Quiquandon, I., Laï, J. L., Pignon, J. M., Loucheux-Lefebvre, M. H., Bauters, F., Berger, R., and Kerckaert, J. P. p53 gene mutations in acute myeloid leukemia with 17p monosomy. Blood, 78: 1652-1657, 1991.
4. Gaidano, G., Ballerini, P., Gong, J. Z., lnghirami, G., Neri, A., Newcomb, E. W., Magrath, I. T., Knowles, D. M., and Dalla Favera, R. p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. USA, 88: 5413-5417, 1991.
5. Nakai, H., Misawa, S., Toguchida, J., Yandell, D. W., and Ishizaki, K. Frequent p53 gene mutations in blast crisis of chronic myelogenous leukemia, especially in myeloid crisis harboring loss of a chromosome 17p. Cancer Res., 52: 6588-6593, 1992.
6. Jonveaux, P., Fenaux, P., Quiquandon, I.. Pignon, J. M., Lai, J. L., Loucheux Lefebvre, M. H., Goossens, M., Bauters, F., and Berger, R. Mutations in the p53 gene in myelodysplastic syndromes. Oncogene, 6: 2243-2247, 1991.
7. Imamura, J., Miyoshi, I., and Koeffler, H. P. p53 in hematologic malignancies. Blood, 84: 2412-2421, 1994.
8. Preudhomme, C., Quesnel, B., Vachee, A., Lepelley, P., Collyn, D. H. M., Wattel, E., and Fenaux, P. Absence of amplification of MDM2 gene, a regulator of p53 function, in myelodysplastic syndromes. Leukemia (Baltimore), 7: 1291-1293, 1993.
9. Prokocimer, M., and Rotter, V. Structure and function of p53 in normal cells and their aberrations in cancer cells: projection on the hematologic cell lineages. Blood, 84: 2391-2411, 1994.
10. Schottelius, A., Brennscheidt, U., Ludwig, W. D., Mertelsmann, R. H., Herrmann, F., and Lubbert, M. Mechanisms of p53 alteration in acute leukemias. Leukemia (Baltimore), 8: 1673-1681, 1994.
11. Bi, S., Hughes, T., Bungey, J., Chase, A., de Fabritiis, P., and Goldman, J. M. p53 in chronic myeloid leukemia cell lines. Leukemia (Baltimore), 6: 839-842, 1992.
12. Sugimoto, K., Toyoshima, H., Sakai, R., Miyagawa, K., Hagiwara, K., Ishikawa, F., Takaku, F., Yazaki, Y., and Hirai, H. Frequent mutations in the p53 gene in human myeloid leukemia cell lines. Blood, 79: 2378-2383, 1992.
13. Feinstein, E., Gale, R. P., Reed, J., and Canaani, E. Expression of the normal p53 gene induces differentiation of K562 cells. Oncogene, 7: 1853-1857, 1992.
14. Johnson, P., Chung, S., and Benchimol, S. Growth suppression of Friend virus-transformed erythroleukemia cells by p53 protein is accompanied by hemoglobin production and is sensitive to erythropoietin. Mol. Cell. Biol., 13: 1456-1463, 1993.
15. Ehinger, M., Nilsson, E., Persson, A. M., Olsson, I., and Gullberg, U. Involvement of the tumor suppressor gene p53 in tumor necrosis factor-induced differentiation of the leukemic cell line K562. Cell Growth Differ., 6: 9-17, 1995.
16. Shaulsky, G., Goldfinger, N., Peled, A., and Rotter, V. Involvement of wild-type p53 in pre-B-cell differentiation in vitro. Proc. Natl. Acad. Sci. USA, 88: 8982-8986, 1991.
17. Soddu, S., Blandino, G., Citro, G., Scardigli, R., Piaggio, G., Ferber, A., Calabretta, B., and Sacchi, A. Wild-type p53 gene expression induces granulocytic differentiation of HL-60 cells. Blood, 83: 2230-2237, 1994.
18. Ehinger, M., Bergh, G., Olofsson, T., Baldetorp, B., Olsson, I., and Gullberg, U. Expression of the p53 tumor suppressor gene induces differentiation and promotes induction of differentiation by 1,25-dihydroxy-cholecalciferol in leukemic U-937 cells. Blood, 87: 1064-1074, 1996.
19. Soddu, S., Blandino, G., Scardigli, R., Coen, S., Marchetti, A., Rizzo, M. G., Bossi, G., Cimino, L., Crescenzi, M., and Sacchi, A. Interference with p53 protein inhibits hematopoietic and muscle differentiation. J. Cell. Biol., 134: 193-204, 1996.
20. el Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., and Vogelstein, B. WAF1, a potential mediator of p53 tumor suppression. Cell, 75: 817-825, 1993.
21. Harper, J. W., Adami, G. R., Wei, N., Keyomarsi, K., and Elledge, S. J. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell, 75: 805-816, 1993.
22. Ewen, M. E., Sluss, H. K., Sherr, C. J., Matsushime, H., Kato, J., and Livingston, D. M. Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell, 73: 487-497, 1993.
23. Kato, J., Matsushime, H., Hiebert, S. W., Ewen, M. E., and Sherr, C. J. Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes Dev., 7: 331-342, 1993.
24. La Thangue, N. B. DRTF1/E2F: an expanding family of heterodimeric transcription factors implicated in cell-cycle control. Trends Biochem. Sci., 19: 108-114, 1994.
25. Deng, C., Zhang, P., Harper, J. W., Elledge, S. J., and Leder, P. Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell, 82: 675-684, 1995.
26. Halevy, O., Novitch, B. G., Spicer, D. B., Skapek, S. X., Rhee, J., Hannon, G. J., Beach, D., and Lassar, A. B. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science (Washington DC), 267: 1018-1021, 1995.
27. Parker, S. B., Eichele, G., Zhang, P., Rawls, A., Sands, A. T., Bradley, A., Olson, E. N., Harper, J. W., and Elledge, S. J. p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells. Science (Washington DC), 267: 1024-1027, 1995.
28. Macleod, K. F., Sherry, N., Hannon, G., Beach, D., Tokino, T., Kinzler, K., Vogelstein, B., and Jacks, T. p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes Dev., 9: 935-944, 1995.
29. Jiang, H., Lin, J., Su, Z. Z., Collart, F. R., Huberman, E., and Fisher, P. B. Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53. Oncogene, 9: 3397-3406, 1994.
30. Steinman, R. A., Hoffman, B., Iro, A., Guillouf, C., Liebermann, D. A., and el Houseini, M. E. Induction of p21 (WAF-1/CIP1) during differentiation. Oncogene, 9: 3389-3396, 1994.
31. Zhang, W., Grasso, L., McClain, C. D., Gambel, A. M., Cha, Y., Travali, S., Deisseroth, A. B., and Mercer, W. E. p53-independent induction of WAF1/CIP1 in human leukemia cells is correlated with growth arrest accompanying monocyte/macrophage differentiation. Cancer Res., 55: 668-674, 1995.
32. Liu, M., Lee, M. H., Cohen, M., Bommakanti, M., and Freedman, L. P. Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes Dev., 10: 142-153, 1996.
33. Lee, E. Y., Chang, C. Y., Hu, N., Wang, Y. C., Lai, C. C., Herrup, K., Lee, W. H., and Bradley, A. Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature (Lond.), 359: 288-294, 1992.
34. Jacks, T., Fazeli, A., Schmitt, E. M., Bronson, R. T., Goodell, M. A., and Weinberg, R. A. Effects of an Rb mutation in the mouse. Nature (Lond.), 359: 295-300, 1992.
35. Chen, P. L., Scully, P., Shew, J. Y., Wang, J. Y., and Lee, W. H. Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation. Cell, 58: 1193-1198, 1989.
36. Kiyokawa, H., Richon, V. M., Venta Perez, G., Rifkind, R. A., and Marks, P. A. Hexamethylenebisacetamide-induced erythroleukemia cell differentiation involves modulation of events required for cell cycle progression through G1. Proc. Natl. Acad. Sci. USA, 90: 6746-6750, 1993.
37. Mihara, K., Cao, X. R., Yen, A., Chandler, S., Driscoll, B., Murphree, A. L., T'Ang, A., and Fung, Y, K. Cell cycle-dependent regulation of phosphorylation of the human retinoblastoma gene product. Science (Washington DC), 246: 1300-1303, 1989.
38. Resnitzky, D., Tiefenbrun, N., Berissi, H., and Kimchi, A. Interferons and interleukin 6 suppress phosphorylation of the retinoblastoma protein in growth-sensitive hematopoietic cells. Proc. Natl. Acad. Sci. USA, 89: 402-406, 1992.
39. Richon, V. M., Rifkind, R. A., and Marks, P. A. Expression and phosphorylation of the retinoblastoma protein during induced differentiation of murine erythroleukemia cells. Cell Growth Differ., 3: 413-420, 1992.
40. Sehy, D. W., Shao, L. E., Yu, A. L., Tsai, W. M., and Yu, J. Activin A-induced differentiation in K562 cells is associated with a transient hypophosphorylation of RB protein and the concomitant block of cell cycle at G1 phase. J. Cell Biochem., 50: 255-265, 1992.
41. Bergh, G., Ehinger, M., Olofsson, T., Baldetorp, B., Johnsson, E., Brycke, H., Lindgren, G., Olsson, I., and Gullberg, U. Altered expression of the retinoblastoma tumor suppressor gene in leukemic cell lines inhibits induction of differentiation but not G1-accumulation. Blood, 89: 2938-2950, 1997.
42. Kato, J. Y., and Sherr, C. J. Inhibition of granutocyte differentiation by G1 cyclins D2 and D3 but not D1. Proc. Natl. Acad. Sci. USA, 90: 11513-11517, 1993.
43. Zhuo, S., Fan, S., Huang, S., and Kaufman, S. Study of the role of retinoblastoma protein in terminal differentiation of murine erythroleukemia cells. Proc. Natl. Acad. Sci. USA, 92: 4234-4238, 1995.
44. Alexandrow, M. G., and Moses, H. L. Transforming growth factor β and cell cycle regulation. Cancer Res., 55: 1452-1457, 1995.
45. Yen, A., Varvayanis, S., and Platko, J. D. 12-O-Tetradecanoylphorbol-13-acetate and staurosporine induce increased retinoblastoma tumor suppressor gene expression with megakaryocytic differentiation of leukemic cells [published erratum appears in Cancer Res., 53: 4119, 1993]. Cancer Res., 53: 3085-3091, 1993.
46. Ronen, D., Schwartz, D., Teitz, Y., Goldfinger, N., and Rotter, V. Induction of HL-60 cells to undergo apoptosis is determined by high levels of wild-type p53 protein whereas differentiation of the cells is mediated by lower p53 levels. Cell Growth Differ., 7: 21-30, 1996.
47. Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Jr., Butel, J. S., and Bradley, A. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature (Lond.), 356: 215-221, 1992.
48. Rudnicki, M. A., Braun, T., Hinuma, S., and Jaenish, R. Inactivation of MyoD in mice leads to up-regulation of the myogenic HLH gene Myf5 and results in apparently normal muscle development. Cell, 71: 383-390, 1992.
49. Shounan, Y., Dolnikov, A., MacKenzie, K. L., Miller, M., Chan, Y. Y., and Symonds, G. Retroviral transduction of hematopoietic progenitor cells with mutant p53 promotes survival and proliferation, modifies differentiation potential and inhibits apoptosis. Leukemia (Baltimore), 10:1619-1628, 1996.
50. Eliyahu, D., Michalovitz, D., and Oren, M. Overproduction of p53 antigen makes established cells highly tumorigenic. Nature (Lond.), 316: 158-160, 1985.
51. Michalovitz, D., Halevy, O., and Oren, M. Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53. Cell, 62: 671-680, 1990.
52. Baker, S. J., Markowitz, S., Fearon, E. R., Willson, J. K., and Vogelstein, B. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science (Washington DC), 249: 912-915, 1990.
53. Sundstrom, C., and Nilsson, K. Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int. J. Cancer, 17: 565-577, 1976.
54. Lozzio, C. B., and Lozzio, B. B. Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. Blood, 45: 321-334, 1975.
55. Collins, S. J., Ruscetti, F. W., Gallagher, R. E., and Gallo, R. C. Normal functional characteristics of cultured human promyelocytic leukemia cells (HL-60) after induction of differentiation by dimethylsulfoxide. J. Exp. Med., 149: 969-974, 1979.